出典: meddic


Wikipedia preview

出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2014/04/03 15:43:30」(JST)

wiki en

[Wiki en表示]

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.


  • Safety and effectiveness of neoadjuvant luteinizing hormone-releasing hormone agonist plus low-dose estramustine phosphate in high-risk prostate cancer: a prospective single-arm study.
  • Koie T, Ohyama C, Yamamoto H, Hatakeyama S, Yoneyama T, Hashimoto Y, Kamimura N.SourceDepartment of Urology, Hirosaki University, Graduate School of Medicine, Hirosaki, Japan.
  • Prostate cancer and prostatic diseases.Prostate Cancer Prostatic Dis.2012 Aug 14. doi: 10.1038/pcan.2012.29. [Epub ahead of print]
  • Background:Radical prostatectomy (RP) has limited cancer control potential for the patient with high-risk prostate cancer (Pca). We prospectively examined the efficacy and safety of neoadjuvant therapy with luteinizing hormone-releasing hormone (LHRH) agonist + low-dose estramustine phosphate (EMP)
  • PMID 22890389
  • Ablation of the ATP-binding cassette transporter, Abca2 modifies response to estrogen-based therapies.
  • Mack JT, Brown CB, Garrett TE, Uys JD, Townsend DM, Tew KD.SourceDepartment of Cell and Molecular Pharmacology and Experimental Therapeutics, Medical University of South Carolina, 173, Ashley Avenue, P.O. Box 250505, Charleston, SC 29425, United States.
  • Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.Biomed Pharmacother.2012 Jul 2. [Epub ahead of print]
  • The ATP-binding cassette transporter 2 (ABCA2) is an endolysosomal protein expressed in oligodendrocytes and Schwann cells, prostate, ovary and macrophages. In cell cultures, ABCA2 over-expression has been linked with resistance to the anticancer agent, estramustine phosphate (EMP; a nor-nitrogen mu
  • PMID 22898081


  • 去勢抵抗性前立腺癌に対するエチニルエストラジオールの有用性
  • 林 拓自,関井 洋輔,片山 欽三,嘉元 章人,角田 洋一,森 直樹,板谷 宏彬,吉岡 俊昭
  • 日本泌尿器科學會雑誌 105(2), 37-42, 2014
  • (目的) エストロゲン製剤であるエチニルエストラジオールの去勢抵抗性前立腺癌に対する効果と有用性について報告する. (対象と方法) 抗アンドロゲン療法を施行後に進行を認めた去勢抵抗性前立腺癌に対して,当科にて2011年8月以降にエチニルエストラジオール1.5~2.0 mg/日を14例に処方した.その14例を対象として,後方視的に効果と有用性について検討した.基本的にアスピリン100 mg/日とLH …
  • NAID 130005076056
  • Outcome, clinical prognostic factors and genetic predictors of adverse reactions of intermittent combination chemotherapy with docetaxel, estramustine phosphate and carboplatin for castration-resistant prostate cancer
  • NARITA Shintaro,TSUCHIYA Norihiko,YUASA Takeshi,MAITA Shinya,OBARA Takashi,NUMAKURA Kazuyuki,TSURUTA Hiroshi,SAITO Mitsuru,INOUE Takamitsu,HORIKAWA Yohei,SATOH Shigeru,HABUCHI Tomonori
  • International journal of clinical oncology 17(3), 204-211, 2012-06-01
  • NAID 10030951423
  • 症例 エストラムスチンとシクロフォスファミドの併用で長期効果が得られている内分泌療法不応前立腺癌
  • 三枝 道尚,西村 慎吾,枝村 康平 [他]
  • 臨床泌尿器科 66(2), 167-170, 2012-02
  • NAID 40019187928


1 Emcyt® estramustine phosphate sodium capsules DESCRIPTION Estramustine phosphate sodium, an antineoplastic agent, is an off-white powder readily soluble in water. EMCYT Capsules are white and opaque, each containing ...
Estramustine for prostate cancer is a treatment used when cancer cells are present in the prostate gland. ... Before taking estramustine Some medicines are not suitable for people with certain conditions, and sometimes a medicine ...


Estramustine sodium phosphateEmcyt (Generic) Estramustine Phosphate Trant - Emcyt (Estramustine) 司汀胶囊)Emcyt (Estramustine Capsules Estracyt 140mg estramustine 100 CapsulesXtrant-Estramustine Phosphate 140mg

拡張検索estramustine phosphate sodium



リン酸エストラムスチンナトリウム, estramustine phosphate sodium

estramustine phosphate sodium」